메뉴 건너뛰기




Volumn 96, Issue 2, 2005, Pages 301-306

Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer

Author keywords

CT; Cytoreduction; MRI; Ovarian cancer

Indexed keywords

ACCURACY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; FEMALE; GALLBLADDER; HUMAN; IMPLANT; LIVER HILUS; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CANCER; PARAAORTIC LYMPH NODE; PERITONEUM; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SMALL INTESTINE;

EID: 12344325535     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.06.054     Document Type: Article
Times cited : (180)

References (27)
  • 1
    • 0027936285 scopus 로고
    • Cancer in older persons: Magnitude of the problem-How do we apply what we know?
    • R. Yancik, and L.A. Ries Cancer in older persons: magnitude of the problem-How do we apply what we know? Cancer 74 Suppl. 7 1994 1995 2003
    • (1994) Cancer , vol.74 , Issue.7 SUPPL. , pp. 1995-2003
    • Yancik, R.1    Ries, L.A.2
  • 2
    • 0032967971 scopus 로고    scopus 로고
    • Diagnosis and staging of ovarian cancer: Comparative values of doppler and conventional US, CT, and MR imaging correlated with surgery and histopathologic analysis-Report of the Radiology Diagnostic Oncology Group
    • A.B. Kurtz, J.V. Tsimikas, C.M. Tempany, U.M. Hamper, P.H. Arger, and R.L. Bree Diagnosis and staging of ovarian cancer: comparative values of doppler and conventional US, CT, and MR imaging correlated with surgery and histopathologic analysis-Report of the Radiology Diagnostic Oncology Group Radiology 212 1999 19 27
    • (1999) Radiology , vol.212 , pp. 19-27
    • Kurtz, A.B.1    Tsimikas, J.V.2    Tempany, C.M.3    Hamper, U.M.4    Arger, P.H.5    Bree, R.L.6
  • 3
    • 0031745255 scopus 로고    scopus 로고
    • Chemotherapy of advanced ovarian cancer
    • W.P. McGuire, and R.F. Ozols Chemotherapy of advanced ovarian cancer Semin. Oncol. 25 1998 340 348
    • (1998) Semin. Oncol. , vol.25 , pp. 340-348
    • McGuire, W.P.1    Ozols, R.F.2
  • 4
    • 0028237380 scopus 로고
    • The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma
    • W.J. Hoskins, W.P. McGuire, M.F. Brady, H.D. Homesley, W.T. Creasman, and M. Berman The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma Am. J. Obstet. Gynecol. 170 1994 974 980
    • (1994) Am. J. Obstet. Gynecol. , vol.170 , pp. 974-980
    • Hoskins, W.J.1    McGuire, W.P.2    Brady, M.F.3    Homesley, H.D.4    Creasman, W.T.5    Berman, M.6
  • 5
    • 0027394686 scopus 로고
    • Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma
    • B.E. Nelson, A.T. Rosenfield, and P.E. Schwartz Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma J. Clin. Oncol. 11 1993 166 172
    • (1993) J. Clin. Oncol. , vol.11 , pp. 166-172
    • Nelson, B.E.1    Rosenfield, A.T.2    Schwartz, P.E.3
  • 6
    • 0022414137 scopus 로고
    • Comparison of cyclophosphamide plus cisplatin versus hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin in combination as initial chemotherapy for stage III and IV ovarian carcinomas
    • J.H. Edmonson, G.W. McCormack, T.R. Fleming, S.A. Cullinan, J.E. Krook, and G.D. Malkasian Comparison of cyclophosphamide plus cisplatin versus hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin in combination as initial chemotherapy for stage III and IV ovarian carcinomas Cancer Treat Rep. 69 1985 1243 1248
    • (1985) Cancer Treat Rep. , vol.69 , pp. 1243-1248
    • Edmonson, J.H.1    McCormack, G.W.2    Fleming, T.R.3    Cullinan, S.A.4    Krook, J.E.5    Malkasian, G.D.6
  • 7
    • 0025860057 scopus 로고
    • Long follow-up and prognostic factor analysis in advanced ovarian carcinoma: The Gynecologic Oncology Group experience
    • G.A. Omura, M.F. Brady, H.D. Homesley, E. Yordan, F.J. Major, and H.J. Buchsbaum Long follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience J. Clin. Oncol. 9 1991 1138 1150
    • (1991) J. Clin. Oncol. , vol.9 , pp. 1138-1150
    • Omura, G.A.1    Brady, M.F.2    Homesley, H.D.3    Yordan, E.4    Major, F.J.5    Buchsbaum, H.J.6
  • 8
    • 0016586897 scopus 로고
    • Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma
    • C. Griffiths Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma Natl. Cancer Inst. Monogr. 42 1975 101 104
    • (1975) Natl. Cancer Inst. Monogr. , vol.42 , pp. 101-104
    • Griffiths, C.1
  • 9
    • 0024506224 scopus 로고
    • Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: A Gynecologic Oncology Group study
    • G.A. Omura, B.N. Bundy, J.S. Berek, S. Curry, G. Delgado, and R. Mortel Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group study J. Clin. Oncol. 7 1989 457 465
    • (1989) J. Clin. Oncol. , vol.7 , pp. 457-465
    • Omura, G.A.1    Bundy, B.N.2    Berek, J.S.3    Curry, S.4    Delgado, G.5    Mortel, R.6
  • 10
    • 0031744447 scopus 로고    scopus 로고
    • The role of surgery in the management of ovarian cancer: Primary and interval cytoreductive surgery
    • M.P. Boente, D.S. Chi, and W.J. Hoskins The role of surgery in the management of ovarian cancer: primary and interval cytoreductive surgery Semin. Oncol. 25 1998 326 334
    • (1998) Semin. Oncol. , vol.25 , pp. 326-334
    • Boente, M.P.1    Chi, D.S.2    Hoskins, W.J.3
  • 11
    • 0036064995 scopus 로고    scopus 로고
    • Staging ovarian cancer: Role of imaging
    • F.V. Coakley Staging ovarian cancer: role of imaging Radiol. Clin. North Am. 40 2002 609 636
    • (2002) Radiol. Clin. North Am. , vol.40 , pp. 609-636
    • Coakley, F.V.1
  • 13
    • 0034307229 scopus 로고    scopus 로고
    • A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography
    • R.E. Bristow, L.R. Duska, N.C. Lambrou, E.K. Fishman, M.J. O'Neill, and E.L. Trimble A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography Cancer 89 2000 1532 1540
    • (2000) Cancer , vol.89 , pp. 1532-1540
    • Bristow, R.E.1    Duska, L.R.2    Lambrou, N.C.3    Fishman, E.K.4    O'Neill, M.J.5    Trimble, E.L.6
  • 15
  • 17
    • 0000065513 scopus 로고    scopus 로고
    • Ovarian cancer, fallopian tube carcinoma, and peritoneal carcinoma
    • V.T. De Vita S. Hellman S.A. Rosenberg Fifth ed. Lippincott-Raven Philadelphia
    • R.F. Ozols, P.E. Schwartz, and P.J. Eifel Ovarian cancer, fallopian tube carcinoma, and peritoneal carcinoma V.T. De Vita S. Hellman S.A. Rosenberg Cancer. Principles and practices of oncology Fifth ed. 1997 Lippincott-Raven Philadelphia 1502 1539
    • (1997) Cancer. Principles and Practices of Oncology , pp. 1502-1539
    • Ozols, R.F.1    Schwartz, P.E.2    Eifel, P.J.3
  • 19
    • 0028231205 scopus 로고
    • Neoadjuvant chemotherapy for advanced ovarian cancer
    • P.E. Schwartz, J.T. Chambers, and R. Makuch Neoadjuvant chemotherapy for advanced ovarian cancer Gynecol. Oncol. 53 1994 33 37
    • (1994) Gynecol. Oncol. , vol.53 , pp. 33-37
    • Schwartz, P.E.1    Chambers, J.T.2    Makuch, R.3
  • 20
    • 0024505272 scopus 로고
    • Tamoxifen in combination chemotherapy with cytotoxic chemotherapy in advanced ovarian cancer: A prospective randomized trial
    • P.E. Schwartz, J.T. Chambers, E.I. Kohorn, S.K. Chambers, H. Weitzman, and I.M. Voynick Tamoxifen in combination chemotherapy with cytotoxic chemotherapy in advanced ovarian cancer: a prospective randomized trial Cancer 63 1989 1074 1078
    • (1989) Cancer , vol.63 , pp. 1074-1078
    • Schwartz, P.E.1    Chambers, J.T.2    Kohorn, E.I.3    Chambers, S.K.4    Weitzman, H.5    Voynick, I.M.6
  • 21
    • 0031012960 scopus 로고    scopus 로고
    • Cytoreductive surgery for the management of stage IV ovarian cancer
    • P.E. Schwartz Cytoreductive surgery for the management of stage IV ovarian cancer Gynecol. Oncol. 64 1997 1 3
    • (1997) Gynecol. Oncol. , vol.64 , pp. 1-3
    • Schwartz, P.E.1
  • 22
    • 0027087151 scopus 로고
    • Ten-year outcome of patients with advanced epithelial ovarian carcinoma treated with cisplatin-based multimodality therapy
    • P.J. Hoskins, S.E. O'Reilly, K.D. Swenerton, J.J. Spinelli, R.N. Fairey, and J.L. Benedet Ten-year outcome of patients with advanced epithelial ovarian carcinoma treated with cisplatin-based multimodality therapy J. Clin. Oncol. 10 1992 1561 1568
    • (1992) J. Clin. Oncol. , vol.10 , pp. 1561-1568
    • Hoskins, P.J.1    O'Reilly, S.E.2    Swenerton, K.D.3    Spinelli, J.J.4    Fairey, R.N.5    Benedet, J.L.6
  • 24
    • 0342981463 scopus 로고    scopus 로고
    • Patterns of care for women with ovarian cancer in the United States
    • K.A. Munoz, L.C. Harlan, and E.L. Trimble Patterns of care for women with ovarian cancer in the United States J. Clin. Oncol. 15 1997 3408 3411
    • (1997) J. Clin. Oncol. , vol.15 , pp. 3408-3411
    • Munoz, K.A.1    Harlan, L.C.2    Trimble, E.L.3
  • 25
    • 0027331504 scopus 로고
    • National survey of ovarian carcinoma. V. Part, the impact of physician's specialty on patients' survival
    • H.N. Nguyen, H.E. Averette, W. Hoskins, M. Penalver, B.U. Sevin, and A. Steren National survey of ovarian carcinoma. V. Part, The impact of physician's specialty on patients' survival Cancer 72 1993 (Dec. 15) 3663 3670
    • (1993) Cancer , vol.72 , pp. 3663-3670
    • Nguyen, H.N.1    Averette, H.E.2    Hoskins, W.3    Penalver, M.4    Sevin, B.U.5    Steren, A.6
  • 26
    • 0034111537 scopus 로고    scopus 로고
    • The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma
    • D.S. Chi, E.S. Venkatraman, V. Masson, and W.J. Hoskins The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma Gynecol. Oncol. 77 2000 227 231
    • (2000) Gynecol. Oncol. , vol.77 , pp. 227-231
    • Chi, D.S.1    Venkatraman, E.S.2    Masson, V.3    Hoskins, W.J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.